Oral News and Research

RSS

What role does dysbiosis play in Parkinson's disease?

The current study, published in the journal Revue Neurologique, is based on the hypothesis that dysbiosis, or unhealthy variations in the gut and oral microbiota, is a key component of PD pathogenesis.

19 Mar 2023

Drug combination may reduce the risk of prostate cancer progression, death

TALAPRO-2, a study led by Neeraj Agarwal, MD, FASCO, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progression or death by 37%.

17 Mar 2023

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age.

17 Mar 2023

Venous thromboembolism is rare among non-hospitalized COVID-19 patients

In a recent study published in the journal JAMA Network Open, researchers in the United States assessed the risk and aimed to identify the independent predictors of venous thromboembolism events in outpatients who had less severe manifestations of coronavirus disease 2019 (COVID-19).

16 Mar 2023

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

More than 37 million Americans have diabetes, and approximately 90-95% have Type 2 diabetes.

16 Mar 2023

Common meat-free proteins may trigger allergic complaints in some legume-allergic patients

Many people keen to reduce their meat consumption are turning to substitutes made of legumes packed with protein, vitamins, and fiber.

16 Mar 2023

MS relapse risk not likely to increase after fertility treatments, study finds

There's good news for those with multiple sclerosis (MS). A new study has found that female participants were no more likely to have a flare-up of the disease after receiving fertility treatments than they were before their treatments.

16 Mar 2023

LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient (API) division and its new contract development and manufacturing (CDMO) division.

From LGM Pharma 16 Mar 2023

Diagnosis and treatment of food allergies using a molecular approach

Researchers discuss molecular methods for food allergy assessments, including diagnostic and prognostic markers, as well as existing therapies.

15 Mar 2023

The role of the fungal mycobiome in women's health

Researchers discuss the association between human mycobiota and female health.

15 Mar 2023

Clinical trial shows promising results for oral psoriasis treatment

A company launched from The University of Queensland's Institute for Molecular Bioscience (IMB) has passed an important milestone in developing an oral treatment for the common skin disease psoriasis.

15 Mar 2023

How does the gut microbiome affect muscle strength?

Researchers use fecal microbiome transplantation in mouse models to examine the role of gut microbiota in determining muscle strength.

14 Mar 2023

Study identifies link between oral and gut microbiomes and depression

Researchers investigate the role of the oral-gut-brain axis in anxiety and depression.

14 Mar 2023

New guideline focuses on the timing of hip and knee arthroplasty

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of its new guideline titled "the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients with Symptomatic Moderate to Severe Osteoarthritis or Osteonecrosis Who Have Failed Nonoperative Therapy."

14 Mar 2023

Long-term antibiotic therapy for adolescent acne can affect liver metabolism and promote adiposity

A growing body of evidence is showing that the healthy gut microbiome – a community of microorganisms that live together in the gut – influences many aspects of human growth and development, especially during adolescence.

14 Mar 2023

Do the symptom profiles among children with SARS-CoV-2 infection differ by variant type?

Researchers performed a comparative analysis of symptoms related to SARS-CoV-2 variants in children.

14 Mar 2023

The development of the pediatric oral resistome and its role in dental caries

Researchers performed a genomic investigation of oral resistome development, i.e., of genes that confer antimicrobial resistance.

14 Mar 2023

Oral host responses to SARS-CoV-2 predict progression of COVID-19

In a recent study posted to the medRxiv* preprint server, researchers at the University of North Carolina and the National Institutes of Health determined the associations between oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), oral antibodies against SARS-CoV-2, and coronavirus disease 2019 (COVID-19) symptoms.

14 Mar 2023

Cholesterol-lowering drugs show potential to reduce heart disease in sleep apnea patients

A new study by Columbia University researchers suggests that cholesterol-lowering drugs called statins have the potential to reduce heart disease in people with obstructive sleep apnea regardless of the use of CPAP machines during the night.

13 Mar 2023

Summarizing the evidence of respiratory transmission of mpox

A recent study published in The Lancet Microbe summarized the evidence for respiratory transmission of mpox (formerly monkeypox).

13 Mar 2023

Oral News and Research

What role does dysbiosis play in Parkinson's disease?

Drug combination may reduce the risk of prostate cancer progression, death

Study confirms the benefit of Paxlovid as an early-stage treatment to prevent COVID-19 hospitalization

Venous thromboembolism is rare among non-hospitalized COVID-19 patients

Phase 2 clinical trial investigates the effectiveness of innovative procedure to control Type 2 diabetes

Common meat-free proteins may trigger allergic complaints in some legume-allergic patients

MS relapse risk not likely to increase after fertility treatments, study finds

LGM Pharma Reports Strong Revenues in First Year of CDMO Operations Along With Continued Growth in Its API Sourcing Business

Diagnosis and treatment of food allergies using a molecular approach

The role of the fungal mycobiome in women's health

Clinical trial shows promising results for oral psoriasis treatment

How does the gut microbiome affect muscle strength?

Study identifies link between oral and gut microbiomes and depression

New guideline focuses on the timing of hip and knee arthroplasty

Long-term antibiotic therapy for adolescent acne can affect liver metabolism and promote adiposity

Do the symptom profiles among children with SARS-CoV-2 infection differ by variant type?

The development of the pediatric oral resistome and its role in dental caries

Oral host responses to SARS-CoV-2 predict progression of COVID-19

Cholesterol-lowering drugs show potential to reduce heart disease in sleep apnea patients

Summarizing the evidence of respiratory transmission of mpox

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News